Systemic neurotransmitter responses to clinically approved and experimental neuropsychiatric drugs

Neuropsychiatric disorders are the third leading cause of global disease burden. Current pharmacological treatment for these disorders is inadequate, with often insufficient efficacy and undesirable side effects. One reason for this is that the links between molecular drug action and neurobehavioral...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nat Commun
Main Authors: Noori, Hamid R., Mervin, Lewis H., Bokharaie, Vahid, Durmus, Özlem, Egenrieder, Lisamon, Fritze, Stefan, Gruhlke, Britta, Reinhardt, Giulia, Schabel, Hans-Hendrik, Staudenmaier, Sabine, Logothetis, Nikos K., Bender, Andreas, Spanagel, Rainer
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6224407/
https://ncbi.nlm.nih.gov/pubmed/30410047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-018-07239-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados